Free Republic

President Donald Trump has had a splendid first year in office. He has the economy moving again and at a healthy pace, some 2.6 percent in the most recent quarter. Unemployment is down, the stock market is up and the economic signs are mostly healthy. Well, for the stock market that was until last week. That was the week in which the President announced his intention to slap a 25 percent tariff on steel imports and a 10 percent tariff on aluminum. The market tanked, and more problems are said to be coming internationally. It appears the world does not...

HERE'S A HUGELY winning issue for President Donald Trump that would deal with a gross trading abuse and simultaneously advance his goal of reducing the prices of prescription drugs: Insist that foreign buyers of American pharmaceuticals--almost without exception government agencies--pay their fair share of the research and development costs of these medicines. Currently, Americans are subsidizing overseas users of our drugs. Here's how that works. The average price of successfully bringing a new medicine to market in the U.S. is about $2.4 billion. The entire approval process takes some 12 years before a drug receives its final green light. The...